BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, May 7, 2026
Breaking News: Read BioWorld's AACR 2026 coverageBreaking News: Best of BioWorld: Q1
Home » Topics » BioWorld

BioWorld
BioWorld RSS Feed RSS

3D rendering of prion structure

AI hacks disordered proteins

Aug. 5, 2025
By Mar de Miguel
No Comments
Deep learning tools for protein design can also be used to create molecules that bind to them. Certain peptides, such as intrinsically disordered proteins (IDPs), are challenging to target due to their variable nature. However, scientists from the lab of Nobel laureate David Baker have developed a method to generate binders for IDPs by searching the world’s largest protein database with their AI-powered tool RFdiffusion.
Read More

Lepu out-licenses T-cell engagers to newco Excalipoint for $857M

Aug. 4, 2025
No Comments
A preview of the next edition of BioWorld, Aug. 4, 2025
Read More

Regulatory actions for Aug. 4, 2025

Aug. 4, 2025
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Artelo, Lenz, Novartis, Novo Nordisk, Poltreg, Regeneron.
Read More

Other news to note for Aug. 4, 2025

Aug. 4, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Altasciences, Arrowhead, Biontech, Endo, Mallinckrodt, Moderna, Nosis, Pfizer, Sanofi, Visirna, Voxcell, Yolo.
Read More

In the clinic for Aug. 4, 2025

Aug. 4, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Allogene, Enegenesis, Spine.
Read More

Financings for Aug. 4, 2025

Aug. 4, 2025
Biopharmas raising money in public or private financings, including: Hemostemix, I-Mab, Kazia, Larimar, Medicinova, Oculis, Silexion, Xbrane.
Read More

Appointments and advancements for Aug. 4, 2025

Aug. 4, 2025
New hires and promotions in the biopharma industry, including: Biomarin, Certara.
Read More

Biggest gainers and losers for July 28-Aug. 1, 2025

Aug. 4, 2025
The top 10 biopharma stock gainers and losers for the week.
Read More

ICYMI: Week in review, July 28-Aug. 1, 2025

Aug. 4, 2025
A quick look back at top stories.
Read More

NME Digest: Q2 2025

Aug. 4, 2025
No Comments
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications during the quarter. You must be a BioWorld Premium subscriber to access this new feature. Contact us to upgrade your account.
Read More
Previous 1 2 … 263 264 265 266 267 268 269 270 271 … 9089 9090 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 7, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • Regulatory actions for May 5, 2026

    BioWorld
    Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing